Sickle Cell Anemia in an Arab Bedouin Village in the Northern Israel
NCT00481039 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2009-09-04
Summary
Sickle cell anemia and sickle cell thalassemia are frequent diseases among the israeli arab population. The purpose of this study is to assess the clinical characteristics of the patients in one arab village and the laboratory characteristics in the carriers of this gene based in the screening for pregnant women that is carried out in the population of northern Israel.
The results can be useful in order to institute universal screening for sickle cell anemia in northern Israel.
Conditions
Interventions
- PROCEDURE
-
Medical history and basic laboratory analysis
Medical history and basic laboratory analysis
Sponsors & Collaborators
-
HaEmek Medical Center, Israel
lead OTHER
Principal Investigators
-
Ariel Koren, MD · Pediatric Hematology Unit, Ha'Emek Medical Center
-
luci Zalman, Phd · Hematology Laboratory - HaEmek Medical Center
-
Tania Flaishman, Student · Pediatric Dpt B - Ha'Emek Medical Center
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-05-31
- Primary Completion
- 2008-12-31
- Completion
- 2008-12-31
Countries
- Israel
Study Locations
More Related Trials
-
Detection of β Thalassemia Carriers by Red Cell Parameters Obtained From the H2 Automatic Counter
NCT00481221 ·Status: UNKNOWN
-
Transfusion in Sickle Cell Disease: Screening of Sickle Cell Disease Trait in Blood Donors
NCT03405688 ·Status: COMPLETED ·Phase: NA
-
Demographic, Clinical and Laboratory Characteristics of Children With Alpha Thalassemia in Northern Israel
NCT00971984 ·Status: COMPLETED
-
Detection Of β-thalassemia Carriers In Assiut
NCT03822585 ·Status: UNKNOWN ·Phase: NA
-
Screening for Alpha Thalassemia in Healthy Volunteers
NCT02692872 ·Status: ACTIVE_NOT_RECRUITING
-
Genetics of Alpha Thalassemia in Israeli Ethnic Groups
NCT00159029 ·Status: COMPLETED
-
Iron Mediated Vascular Disease in Sickle Cell Anemia Patients
NCT01239901 ·Status: COMPLETED
-
The Implementation of the Automated Erythrocytapheresis in Egyptian Sickle Cell Disease Center
NCT03903289 ·Status: RECRUITING ·Phase: NA
-
Long Term Follow up in Sickle Cell Patients Treated by Hydroxyurea
NCT00480974 ·Status: COMPLETED
-
Transfusion in Sickle Cell Disease: Risk Factors for Alloimmunization
NCT03405402 ·Status: COMPLETED ·Phase: NA
-
Demographic, Clinical, Laboratory and Genetical Characteristics of Patients With Beta Thalassemia Intermedia
NCT01443312 ·Status: COMPLETED
-
Evaluation of Therapeutic Adherence to Inciting Spirometry in Sickle Cell Patients
NCT04667325 ·Status: COMPLETED
-
Iron Overload Assesment in Sickle Cell Anemia and Sickle Cell Thalassemia
NCT00512226 ·Status: COMPLETED ·Phase: NA
-
Sickle Cell Disease: A Retrospective Chart Review
NCT01441375 ·Status: COMPLETED
-
Evaluation of the Hemostatic Potential in Sickle Cell Disease Patients
NCT02565082 ·Status: COMPLETED ·Phase: NA
-
Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation
NCT04093986 ·Status: RECRUITING
-
Pilot Study "AHSP as a Biomarker of Sickle Cell Disease in a Population of Adults and Children"
NCT06735625 ·Status: RECRUITING ·Phase: NA
-
Choroidal Thickness in Beta-thalassemia Patients
NCT04067258 ·Status: COMPLETED
-
Evaluating People With Thalassemia: The Thalassemia Longitudinal Cohort (TLC) Study
NCT00661804 ·Status: COMPLETED
-
Carbon Monoxide Levels and Sickle Cell Disease Severity
NCT01547793 ·Status: COMPLETED
-
Invasive Infections in Children With Hemoglobinopathies
NCT00456443 ·Status: COMPLETED
-
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
NCT06609226 ·Status: RECRUITING ·Phase: PHASE3
-
Bone Loss, Physical Function and Frailty in Older Women With Sickle Cell Trait Sickle Cell Trait
NCT07083531 ·Status: RECRUITING
-
The Spleen in Sickle Cell Anemia and Sickle Cell Thalassemia
NCT00971698 ·Status: COMPLETED
-
Exploration of the Parameters Influencing the Effort Limitation of Patients Suffering From Homozygous Sickle Cell Anemia
NCT06743139 ·Status: COMPLETED